Newsroom

Press Releases

March 06, 2018

23andMe Granted First FDA Authorization for Direct-to-Consumer Genetic Test on Cancer Risk

Authorization allows 23andMe to report on BRCA1- and BRCA2-related genetic risk for breast, ovarian and prostate cancerMountain View, California – March 6, 2018 – 23andMe, Inc., the leading personal genetics…
September 18, 2017

National Survey Shows Strong Interest In DNA Testing

Survey also Reveals a Need for Improved Genetic and Science Literacy MOUNTAIN VIEW, Calif. — September 18, 2017 — Most Americans are interested in using DNA testing to understand more…
September 12, 2017

23andMe Raises $250 Million in Growth Financing Led by Sequoia Capital

Following this year’s landmark FDA clearance for genetic health reports, company will use funds to fuel customer growth and further invest in its research platformMOUNTAIN VIEW, Calif. – September 12,…